adenosine has been researched along with Adenocarcinoma in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (20.75) | 18.7374 |
| 1990's | 6 (11.32) | 18.2507 |
| 2000's | 4 (7.55) | 29.6817 |
| 2010's | 9 (16.98) | 24.3611 |
| 2020's | 23 (43.40) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, D; Guo, Y; Hua, L; Li, J; Li, S; Liu, X; Ma, P; Min, J; Shi, J; Song, Y; Su, H; Wang, R; Yang, C; Zhang, C; Zhao, T; Zhu, L | 1 |
| Li, F; Zhang, P | 1 |
| Hou, Q; Liu, J; Liu, L; Wu, L; Zhong, Y | 1 |
| Cui, J; Du, X; Ke, J; Ma, B; Yang, X; Yu, L | 1 |
| Ding, R; Li, Y; Liu, P; Pan, D; Wu, T; Xing, L; Yang, R; Yang, X; Zhang, X | 1 |
| Akita, H; Chijimatsu, R; Doki, Y; Eguchi, H; Ishii, H; Kobayashi, S; Konno, M; Mitsufuji, S; Motooka, D; Murakumo, Y; Ogawa, K; Tamari, K; Tatekawa, S | 1 |
| Jiang, Y; Sheng, P; Zhang, T | 1 |
| Chen, H; Hu, B; Lyu, Y; Qian, D; Shao, G; Yan, Q; Zhu, L | 1 |
| Abudurufu, M; Cai, HY; Chen, TF; Ke, ZF; Lei, YY; Luo, HH; Shan, SC; Yang, HS; Zhu, Y; Zou, JY | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; He, T; Zhang, L; Zhang, W | 1 |
| Gao, H; Li, Y; Shi, G; Wang, Y; Wei, Y | 1 |
| Fu, J; Qin, X; Wang, Y; Xing, C; Zhang, Y; Zhang, Z | 1 |
| Fu, N; Teng, Y; Xi, Y; Zhao, X | 1 |
| Jin, LP; Liu, T; Sun, YW; Tai, JD | 1 |
| Jin, L; Li, C; Liu, T; Wang, L | 1 |
| Shao, J; Song, H; Wang, J; Xu, D | 1 |
| Gao, H; Geng, X; Jing, J; Li, L; Mou, Y; Pan, W; Tu, J; Wang, J; Wu, H; Zhang, C; Zhou, X | 1 |
| Cai, W; Du, Q; Mao, J; Mo, P; Ruan, J; Xie, S; Ye, J | 1 |
| Liu, JH; Ou-Yang, S; Wang, QZ | 1 |
| Kuai, D; Liu, H; Liu, T; Min, L; Shi, H; Yang, R; Zhang, S; Zhu, S | 1 |
| Guo, W; He, Y; Yu, X; Zhang, Q; Zheng, Q | 1 |
| Li, L; Li, S; Ren, J; Shang, D; Xiang, K; Yuan, Q | 1 |
| Li, H; Li, T; Shen, J; Wang, L; Wu, Q; Xu, Y; Zhang, S | 1 |
| Zhang, X; Zhang, Z | 1 |
| Chen, H; Cheng, Q; Huang, R; Li, S; Qian, Y; Shao, Z; Wang, H; Xiang, M; Xie, R; Xu, N; Xu, Q; Zhou, Z | 1 |
| Aliagas, E; Condom, E; Martín-Satué, M; Ponce, J; Texidó, L; Vidal, A | 1 |
| Behrens, C; Coombes, KR; Girard, L; Heymach, J; Hong, WK; Lee, JJ; Lin, HY; Minna, JD; Nilsson, MB; Riquelme, E; Simon, G; Suraokar, M; Wang, J; Wistuba, II | 1 |
| Balzarini, J; Peterson, MA; Shelton, JR | 1 |
| Ahlmanner, F; Bastid, J; Börjesson, L; Fredin, K; Gustavsson, B; Langenes, V; Ndah, TG; Quiding-Järbrink, M; Stenstad, H; Sundström, P; Theander, L | 1 |
| Aghaei, M; Fallahian, F; Karami-Tehrani, F; Panjehpour, M; Salami, S | 1 |
| Eitaki, M; Inanami, O; Matsuda, A; Meike, S; Yamamori, T; Yasui, H | 1 |
| Bednarek, A; Fabianowska-Majewska, K; Salamé, P; Stefanska, B | 1 |
| Barrett, DA; Fouladi-Nashta, AA; Halliday, N; Li, D; Sinclair, KD; Singh, R | 1 |
| Baraldi, S; Benini, A; Borea, PA; Cattabriga, E; Feo, C; Gessi, S; Leung, E; Mac Lennan, S; Merighi, S; Mirandola, P; Varani, K | 1 |
| Alauddin, MM; Conti, PS; Fissekis, JD; Park, R; Shahinian, A; Tohme, M | 1 |
| Blay, J; Hoskin, DW; MacKenzie, WM | 2 |
| Figarella, C; Merten, M; Montserrat, C | 1 |
| Belleri, M; Morbidelli, L; Presta, M; Ribatti, D; Rusnati, M; Ziche, M | 1 |
| Akita, H; Itoh, Y; Kohri, K; Tozawa, K; Ueda, K; Yasui, T | 1 |
| Hakala, MT; Slocum, HK | 1 |
| Anderson, LM; Budinger, JM; Giner-Sorolla, A; Greenbaum, JH; Last-Barney, K | 1 |
| Matsunaga, H; Strong, LC | 4 |
| Gutmann, HR; Rydell, RE; Yost, Y | 1 |
| Cabantchik, ZI; Eidelman, O; Fox, C; Guay-Broder, C; Jacobson, KA; Pollard, HB; Turner, RJ; van Galen, PJ | 1 |
| Borzenko, BG; Dumanskiĭ, IuV; Gorbachev, AA; Shepliakov, MN; Shevchenko, VV | 1 |
| Fontaine, J; Rapaport, E | 1 |
| Chin, PC; Franklin, CC; Kim, HD; Turner, JT | 1 |
| Fleysher, MH | 1 |
| Allan, PW; Bennett, LL; Hill, DL; Straight, S | 1 |
53 other study(ies) available for adenosine and Adenocarcinoma
| Article | Year |
|---|---|
Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Topics: Adenocarcinoma; Adenosine; Biomarkers, Tumor; Cohort Studies; Databases, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kaplan-Meier Estimate; Methylation; Pancreatic Neoplasms; Prognosis; RNA; Transcriptome; Tumor Microenvironment | 2021 |
The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Biomarkers, Tumor; Computational Biology; Databases, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Male; Methylation; Pancreatic Neoplasms; Prognosis; Proportional Hazards Models; Protein Interaction Maps; RNA-Binding Proteins | 2021 |
Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model.
Topics: Adenocarcinoma; Adenosine; Humans; Lung; Prognosis; RNA, Long Noncoding | 2022 |
[Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Methylation; Tumor Microenvironment | 2022 |
Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis.
Topics: Adenocarcinoma; Adenosine; Colonic Neoplasms; Humans; Methylation; Prognosis; RNA; Tumor Microenvironment | 2022 |
N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Cell Cycle; Cell Cycle Proteins; Homeostasis; Humans; Methylation; Methyltransferases; Pancreatic Neoplasms; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA-Binding Proteins | 2022 |
m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Cell Line, Tumor; Datasets as Topic; Humans; Lymphocytes; Macrophages; Methylation; Neutrophils; Pancreatic Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger | 2023 |
A novel algorithm for lung adenocarcinoma based on N6 methyladenosine-related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti-tumor therapies.
Topics: Adenocarcinoma; Adenosine; Algorithms; Antineoplastic Agents; Humans; Lung; Lung Neoplasms; Prognosis; RNA, Long Noncoding; Tumor Microenvironment | 2022 |
Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in 'driver-gene-negative' lung adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Humans; Lung; Lung Neoplasms; Methylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; RNA, Long Noncoding; Tumor Microenvironment | 2023 |
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Topics: Adenocarcinoma; Adenosine; Carcinoma, Hepatocellular; COVID-19; Dipeptidyl Peptidase 4; Female; Humans; Immunity; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Pancreatic Neoplasms; Pandemics; Prospective Studies; SARS-CoV-2; Skin Neoplasms | 2023 |
Development a m
Topics: Adenocarcinoma; Adenosine; DNA Copy Number Variations; Humans; Immunotherapy; Prognosis; Stomach Neoplasms; Tumor Microenvironment | 2023 |
METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Angiopoietin-Like Protein 3; Animals; Methyltransferases; Mice; RNA; RNA, Messenger; Stomach Neoplasms | 2023 |
N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Biomarkers; Humans; Lung Neoplasms; Prognosis | 2023 |
Screening of m6A gene-related lncRNAs in colon adenocarcinoma and construction of a prognostic prediction model.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine; Cell Adhesion Molecules; Colonic Neoplasms; Guanylate Kinases; Humans; Prognosis; RNA, Long Noncoding | 2023 |
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Adenosine Triphosphatases; Algorithms; Cluster Analysis; Colon; Colonic Neoplasms; Databases, Genetic; Gene Expression Profiling; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Methylation; Methyltransferases; Multivariate Analysis; Prognosis; RNA; RNA Helicases; RNA-Binding Proteins; tRNA Methyltransferases | 2019 |
The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Aged; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methyltransferases; Middle Aged; Prognosis; Protein Domains; RNA-Binding Proteins; Transcriptome | 2020 |
Circular RNA expression profile and m6A modification analysis in poorly differentiated adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adenosine; Aged; Cell Line, Tumor; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; RNA, Circular; Stomach Neoplasms | 2020 |
Topics: Adenocarcinoma; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Humans; Immune Checkpoint Proteins; Methylation; Retrospective Studies; RNA; RNA Helicases; Stomach | 2020 |
Expression patterns and a prognostic model of m
Topics: Adenocarcinoma; Adenosine; Aged; Biomarkers, Tumor; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Proteins; Prognosis; Prostatic Neoplasms; Risk Assessment | 2020 |
Aberrant expression of m
Topics: Adenocarcinoma; Adenoma; Adenosine; Biomarkers, Tumor; Case-Control Studies; Colorectal Neoplasms; DNA Methylation; Eukaryotic Initiation Factor-3; Female; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Nerve Tissue Proteins; Prognosis; RNA Splicing Factors; RNA-Binding Proteins; RNA, Messenger | 2021 |
Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Topics: Adenocarcinoma; Adenosine; AlkB Homolog 1, Histone H2a Dioxygenase; Biomarkers, Tumor; Computational Biology; Humans; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; RNA Processing, Post-Transcriptional | 2021 |
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Aged; Cohort Studies; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Risk Factors; RNA, Long Noncoding; Signal Transduction | 2021 |
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adenosine; Aged; Biomarkers, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; RNA; ROC Curve; Tumor Microenvironment | 2021 |
Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer.
Topics: Adenocarcinoma; Adenosine; Biomarkers, Tumor; Colonic Neoplasms; Datasets as Topic; Epigenesis, Genetic; Esophageal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Methylation; Prognosis; Protein Interaction Maps; Rectal Neoplasms; Survival Analysis | 2021 |
Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Topics: Adenocarcinoma; Adenosine; Animals; Bone Marrow Cells; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Culture Media, Conditioned; Dendritic Cells; Epigenesis, Genetic; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methylation; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Pancreatic Neoplasms; Phenylurea Compounds; Signal Transduction; Thiostrepton; Wnt-5a Protein | 2019 |
High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.
Topics: 5'-Nucleotidase; Adenocarcinoma; Adenosine; Aged; Aged, 80 and over; Antigens, CD; Apyrase; Endometrial Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Middle Aged | 2014 |
VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Signal Transduction; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2014 |
Discovery of a nanomolar inhibitor of lung adenocarcinoma in vitro.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine; Antineoplastic Agents; Binding Sites; Bone Morphogenetic Protein Receptors, Type I; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Lung Neoplasms; Molecular Docking Simulation; Structure-Activity Relationship | 2014 |
Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism.
Topics: Adenocarcinoma; Adenosine; Antigens, CD; Apyrase; Cells, Cultured; Coculture Techniques; Colonic Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; T-Lymphocytes, Regulatory; Transendothelial and Transepithelial Migration | 2016 |
Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
Topics: Adenocarcinoma; Adenosine; Androgens; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Purinergic P1 | 2012 |
8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells.
Topics: Adenocarcinoma; Adenosine; Adenosine Triphosphate; Apoptosis; Caspase Inhibitors; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Radiation; Humans; Microscopy, Fluorescence; Multiple Myeloma; Peptides; Propidium; Radiation-Sensitizing Agents; Signal Transduction; X-Rays | 2011 |
Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells.
Topics: Adenocarcinoma; Adenosine; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cholecalciferol; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasm Proteins; Promoter Regions, Genetic; PTEN Phosphohydrolase; Resveratrol; RNA, Messenger; Stilbenes; Tretinoin; Vitamins | 2012 |
Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation.
Topics: Adenocarcinoma; Adenosine; Alkaline Phosphatase; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cyclic AMP; Extracellular Signal-Regulated MAP Kinases; HT29 Cells; Humans; Hypoxanthines; MAP Kinase Kinase Kinases; Methionine; Methotrexate; Phosphatidylinositol 3-Kinases; Polyamines; Purines; Signal Transduction; Tetrahydrofolates; Thymidine | 2006 |
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
Topics: Adenocarcinoma; Adenosine; Blotting, Western; Caco-2 Cells; Cell Division; Colorectal Neoplasms; Cyclic AMP; HT29 Cells; Humans; Ligands; Radioligand Assay; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Thymidine | 2007 |
Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives.
Topics: Adenocarcinoma; Adenosine; Animals; HT29 Cells; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2007 |
Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.
Topics: Adenocarcinoma; Adenosine; Animals; Antibodies; CD3 Complex; Cell Adhesion; Colonic Neoplasms; Killer Cells, Natural; Mice; Theobromine; Thioinosine; Tumor Cells, Cultured; Xanthines | 1994 |
Defective ATP-dependent mucin secretion by cystic fibrosis pancreatic epithelial cells.
Topics: Adenocarcinoma; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adult; Antigens; Calcium; Carbachol; Cell Line; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelium; Humans; Immunoassay; Mucins; Pancreatic Neoplasms; Receptors, Purinergic P2; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1996 |
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Topics: 2-Aminopurine; Adenocarcinoma; Adenosine; Allantois; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Aorta; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Cattle; Cells, Cultured; Chick Embryo; Chorion; Cornea; Depression, Chemical; Endometrial Neoplasms; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Humans; Mercaptopurine; Methylthioinosine; Mice; Mitogen-Activated Protein Kinase 1; Neoplasm Transplantation; Neovascularization, Physiologic; Phosphorylation; Protein Processing, Post-Translational; Rabbits; Recombinant Fusion Proteins; Signal Transduction; Transfection | 1999 |
CAG repeats in the androgen receptor: a case of spinal and bulbar muscular atrophy associated with prostate cancer.
Topics: Adenocarcinoma; Adenosine; Cytidine; Guanosine; Humans; Male; Middle Aged; Muscular Atrophy, Spinal; Prostatic Neoplasms; Receptors, Androgen; Trinucleotide Repeats | 1999 |
Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.
Topics: Adenocarcinoma; Adenosine; Animals; Antibodies; Cell Adhesion; Cells, Cultured; Colonic Neoplasms; Fibronectins; Immunosuppressive Agents; Integrin alpha4beta1; Integrins; Lymphocyte Function-Associated Antigen-1; Mice; Mice, Inbred C57BL; Receptors, Fibronectin; Receptors, Lymphocyte Homing; T-Lymphocytes; Tumor Cells, Cultured; Vascular Cell Adhesion Molecule-1 | 2002 |
Mechanism of natural resistance to N6-(delta2-isopentenyl)adenosine in cultured cells.
Topics: Adenocarcinoma; Adenosine; Alkenes; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cells, Cultured; Chromatography, Paper; Drug Resistance; Humans; Kidney; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Pentosyltransferases; Phosphates; Phosphotransferases; Sarcoma 180; Tritium | 1975 |
Induction of reproductive system tumors in mice by N6-(methylnitroso)-adenosine and a tumorigenic effect of its combined precursors.
Topics: Adenocarcinoma; Adenosine; Animals; Female; Leiomyoma; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Nitrites; Nitrosamines; Nitroso Compounds; Ovarian Neoplasms; Uterine Neoplasms | 1979 |
A second method for induction of a transmissible entity in the control of cancer in mice.
Topics: Adenocarcinoma; Adenosine; Animals; Cytidine; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H | 1976 |
The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Topics: Acetamides; Acetates; Adenocarcinoma; Adenoma; Adenosine; Animals; Carbon Radioisotopes; Carcinogens; Cell Nucleus; Electrochemistry; Esters; Female; Fluorenes; Guanosine; Hydroxamic Acids; Injections, Intramuscular; Injections, Intraperitoneal; Isomerism; Male; Mammary Neoplasms, Experimental; Methionine; Nitrogen; Rats; RNA, Transfer; Structure-Activity Relationship | 1975 |
A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells.
Topics: 2-Chloroadenosine; Adenocarcinoma; Adenosine; Cell Line; Chlorides; Chromosome Deletion; Colonic Neoplasms; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genotype; Humans; Kinetics; Membrane Proteins; Mutation; Pancreatic Neoplasms; Phenotype; Purinergic Antagonists; Xanthines | 1992 |
[Activity of the enzymes of DNA metabolism in the blood of patients with breast cancer].
Topics: 5'-Nucleotidase; Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenosine; Adenosine Deaminase; Age Factors; Aged; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Middle Aged; Postoperative Care; Preoperative Care; Thymidine; Thymidine Kinase; Thymidine Phosphorylase | 1990 |
Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools.
Topics: Adenocarcinoma; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antineoplastic Agents; Colonic Neoplasms; Erythrocytes; Mice; Weight Loss | 1989 |
Insulin regulation of glucose metabolism in HT29 colonic adenocarcinoma cells: activation of glycolysis without augmentation of glucose transport.
Topics: 3-O-Methylglucose; Adenocarcinoma; Adenosine; Adenosine Triphosphate; Biological Transport; Colonic Neoplasms; Cytochalasin B; Epithelium; Glucose; Glycolysis; Hexoses; Insulin; Insulin-Like Growth Factor I; Methylglucosides; Monosaccharide Transport Proteins; Tumor Cells, Cultured | 1988 |
N 6 -Substituted adenosines: synthesis, biological activity, and some structure-activity relationships.
Topics: Adenocarcinoma; Adenosine; Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, Paper; Escherichia coli; Female; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Nicotiana; Optical Rotation; Plants, Toxic; Sarcoma 180; Spectrum Analysis; Structure-Activity Relationship; Ultraviolet Rays | 1972 |
Comparative effect of three nucleosides on suppression of cancer growth in mice.
Topics: Adenocarcinoma; Adenosine; Age Factors; Animals; Cytosine; Female; Injections, Intraperitoneal; Liver Extracts; Mammary Neoplasms, Experimental; Methods; Mice; Mice, Inbred C3H; Time Factors | 1973 |
Comparison of the effect of three nucleosides and a liver emulsion upon the inhibition of cancer in mice.
Topics: Adenocarcinoma; Adenosine; Animals; Cytidine; Emulsions; Injections, Intraperitoneal; Liver Extracts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Solutions | 1972 |
The stimulation and inhibition of the growth capacities of spontaneous tumors of mammary gland origin in mice (adenocarcinomata).
Topics: Adenocarcinoma; Adenosine; Age Factors; Animals; Cytidine; Emulsions; Immunogenetics; Liver Extracts; Mammary Neoplasms, Experimental; Mice; Preservation, Biological; Temperature | 1971 |
Inhibition of guanine metabolism of mammalian tumor cells by the carbocyclic analogue of adenosine.
Topics: Adenine; Adenocarcinoma; Adenosine; Carbon Isotopes; Cells, Cultured; Chromatography, Paper; Cyclopentanes; Guanine; Guanine Nucleotides; Hypoxanthines; Inosine Nucleotides; Kinetics; Neoplasms, Experimental; Pentosephosphates; Pentosyltransferases; Phosphotransferases | 1971 |